14-Day Trial ⭐ Get Full Access to Premium Tools FREE 14-Day Trial ⭐ Get Full Access FREE
$1.30
+0 (+0%)
At Close: Mar 19, 2025
Forecast Earnings Insider Trading Signals Historical Prices Predictions News Profile

Eagle Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 53.07. In total, the insiders bought 913 819 and sold 232 728 EGRX shares in the last 100 trades.

Insider Power

(Last 100 transactions) 		53.07
Buy 913 819 Shares
Sell 232 728 Shares

Historical Insider Trades

Date Type Action Person Amount
Nov 11, 2024 Buy Krawtschuk Christopher 0
Feb 28, 2024 Common Stock Sell Tarriff Scott 2 119
Feb 27, 2024 Common Stock Buy Cahill Brian Joseph 3 800
Feb 27, 2024 Common Stock Sell Cahill Brian Joseph 1 589
Feb 27, 2024 Common Stock Buy Tarriff Scott 12 950
Feb 27, 2024 Common Stock Sell Tarriff Scott 3 154
Feb 02, 2024 Common Stock Sell Cahill Brian Joseph 934
Jan 05, 2024 Common Stock Sell Cahill Brian Joseph 735
Jan 05, 2024 Common Stock Sell Tarriff Scott 4 322
Dec 21, 2023 Employee Stock Option (right to buy) Buy Graves Michael 293 000
Dec 18, 2023 Common Stock Sell Cahill Brian Joseph 452
Nov 02, 2023 Common Stock Sell Tarriff Scott 10 694
Nov 01, 2023 Common Stock Sell Tarriff Scott 10 925
Oct 27, 2023 Common Stock Buy Graves Michael 9 360
Oct 27, 2023 Stock Option (right to buy) Sell Graves Michael 9 360
Oct 03, 2023 Common Stock Sell Tarriff Scott 10 024
Oct 03, 2023 Common Stock Sell Tarriff Scott 710
Oct 02, 2023 Common Stock Sell Tarriff Scott 9 511
May 16, 2023 Common Stock Sell Tarriff Scott 15 000
May 15, 2023 Common Stock Sell Tarriff Scott 14 800
May 15, 2023 Common Stock Sell Tarriff Scott 200
May 12, 2023 Common Stock Sell Tarriff Scott 3 131
May 12, 2023 Common Stock Sell Tarriff Scott 11 869
May 11, 2023 Common Stock Sell Tarriff Scott 15 000
Mar 07, 2023 Stock Option (right to buy) Buy Ratoff Steven B 16 253
Click to get the best stock tips daily for free!
ABOUT EAGLE PHARMACEUTICALS
Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium ...
Read Full Profile Here
GOLDEN STAR
Ticker Change Signal Date
F
FALN
$26.89
0.335% Mar 17
A
ANGL
$28.92
0.380% Mar 17
PFE
$26.05
0.614% Mar 17
AMED
$92.57
0.346% Mar 14
WTS
$211.00
1.00% Mar 14
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE